Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
Open Access
- 1 July 2008
- journal article
- editorial
- Published by American Diabetes Association in Diabetes
- Vol. 57 (7) , 1788-1789
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in MiceDiabetes, 2008
- Insulin as an autoantigen in NOD/human diabetesCurrent Opinion in Immunology, 2008
- Recognition of self-peptide–MHC complexes by autoimmune T-cell receptorsTrends in Biochemical Sciences, 2007
- Prime role for an insulin epitope in the development of type 1 diabetes in NOD miceNature, 2005
- Molecular Interactions Mediating T Cell Antigen RecognitionAnnual Review of Immunology, 2003
- Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: Similarity to the major histocompatibility complex class II I-Ag7 protein of non-obese diabetic miceEuropean Journal of Immunology, 1997
- Integrin α chain cytoplasmic tails regulate “antibody‐redirected” cell adhesion, independently of ligand bindingEuropean Journal of Immunology, 1997
- Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.Journal of Clinical Investigation, 1996
- Low avidity recognition of self-antigen by T cells permits escape from central toleranceImmunity, 1995
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995